The reciprocal antagonism between the actions of Rac1 and RhoA on breast cancer cell NHE1 activity, motility and invasive capacity is identical to that reported for movement/migration [21,22] and actin cytoskeleton remodelling [12,40] in other cell systems. Here, SLC9A1 is linked to breast carcinoma.